Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Ketamine-Induced Psychologic Side Effects
NCT03831854Phase 3Completed
- Sponsor
- Cleveland Clinic
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in drug-induced psychosis comparing Lamotrigine with Placebo (2 arms). Primary endpoints: Psychologic Side-effects measured by Brief Psychiatric Rating Scale (BPRS) at 90 minutes and Number of Patients With Psychologic Disturbances at 90 minutes. Started Jan 2019; status: completed.
02
Drugs
lamotrigine
03
Conditions
drug-induced psychosis
Beyond the preview
Go deeper on NCT03831854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03831854.